A medical breakthrough is showing promise for Americans with Type 1 diabetes. It's an alternative for taking insulin without ...
New data highlight the potential benefits of using berobenatide, an investigational injectable glucagon-like peptide-1 receptor agonist (GLP-1 RA) across patient populations—including in individuals ...
Delivering Sarclisa via an under-the-skin injection may improve the quality of life of patients with pretreated relapsed, refractory multiple myeloma, according to recent research. Treatment with ...
A single subcutaneous injection of the investigational drug zilebesiran, when added to existing treatment with a standard antihypertensive medication, reduced systolic blood pressure by between 4 to ...
A serious condition of fatty liver called MASH (Metabolic dysfunction-associated steatohepatitis) is on the rise worldwide, alongside obesity and type 2 diabetes. If it is left unchecked, it can scar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results